Atrinsic, Inc. reported raising $3.47 Million in an initial SEC Form D filing, from an offering of $5.5 Million
PUBLIC · PTIXFeb 23, 2016$3.5M of $5.5M raised
Amount Raised
$3.47 Million
$3.47 Million sold, per SEC Form D (first sale Feb 23, 2016)
Round Type
Seed
New YorkBiotechnologyHealth CareTherapeuticsBiopharmaWho to call at Protagenic Therapeutics, and when
A new round usually means Protagenic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Protagenic Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Protagenic Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Protagenic Therapeutics. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Protagenic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Protagenic Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.